Theracryf Plc
TCF.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £1 | £0 | £0 |
| Gross Profit | -£0 | -£1 | -£0 | -£0 |
| % Margin | – | – | – | – |
| R&D Expenses | £0 | £0 | £0 | £2 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £1 | £0 | £1 | £2 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£0 | £0 | -£2 |
| Operating Expenses | £1 | £0 | £1 | £2 |
| Operating Income | -£1 | -£1 | -£1 | -£2 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | -£1 | -£1 | -£1 | -£2 |
| Tax Expense | £0 | £0 | £0 | -£0 |
| Net Income | -£1 | -£1 | -£1 | -£2 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.001 | -0.005 | -0.006 |
| % Growth | 100% | 75.6% | 26.2% | – |
| EPS Diluted | 0 | -0.001 | -0.005 | -0.006 |
| Weighted Avg Shares Out | 2,146 | 641 | 275 | 275 |
| Weighted Avg Shares Out Dil | 2,146 | 653 | 275 | 275 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£1 | -£1 | -£1 | -£2 |
| % Margin | – | – | – | – |